Background illustration for clinical trials search

Paid Clinical Trials Minnesota

Discover 1,919 paid clinical trials in Minnesota. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.

Filter
1

Study of AZD5863 in Adult Participants With Advanced or Metastatic Solid Tumors

for
Gastric Cancer, Gastro-esophageal Junction Cancer,
Location: Jacksonville FL, Rochester MN
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06005493

Phase 1, Phase 2, Recruiting

A Dose Escalation Study of Levetiracetam in the Treatment of Neonatal Seizures

for
Neonatal Seizure, Neonatal Encephalopathy,
Location: Minneapolis MN
Sponsor: University of California, San Diego

Sex: All

Age: 0

Code: NCT05610085

Phase 2, Recruiting

Registry of Patients Prescribed Anticoagulation

for
Acute Deep Vein Thrombosis, Acute Pulmonary Embolism
Location: Rochester MN
Sponsor: Mayo Clinic

Sex: All

Age: 18+

Code: NCT03504007

Recruiting

JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort C: Bevacizumab

for
Acute Respiratory Distress Syndrome (ARDS), ARDS,
Location: Burlington MA, The Bronx NY, New Brunswick NJ,
Sponsor: PPD Development, LP

Sex: All

Age: 18+

Code: NCT06701656

Phase 2, Recruiting

Study of Lunresertib Alone or in Combination With RP-3500 or Debio 0123 in Patients With Advanced Solid Tumors

for
Advanced Solid Tumor
Location: Boston MA, Providence RI, New Haven CT,
Sponsor: Debiopharm International SA

Sex: All

Age: 12+

Code: NCT04855656

Phase 1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

AAV Gene Therapy Clinical Study in Adult Classic PKU (PHEdom)

for
Phenylketonurias
Location: Morristown NJ, Pittsburgh PA, Minneapolis MN, Dallas TX,
Sponsor: NGGT INC.

Sex: All

Age: 18 - 55

Code: NCT06332807

Phase 1, Phase 2, Recruiting

Ivosidenib in Participants With Locally Advanced or Metastatic Conventional Chondrosarcoma Untreated or Previously Treated With 1 Systemic Treatment Regimen

for
Locally Advanced or Metastatic Conventional Chondrosarcoma With an IDH1 Mutation, Untreated or Previously Treated With 1 Systemic Treatment Regimen,
Location: Boston MA, New Haven CT, New York NY, Baltimore MD,
Sponsor: Servier Bio-Innovation LLC

Sex: All

Age: 18+

Code: NCT06127407

Phase 3, Recruiting

A Single-arm, Pivotal Study to Evaluate Acute Device and Technical Success of the CGuard Prime Carotid Stent System When Used in Conjunction to the ENROUTE Transcarotid Neuroprotection System in Patients Undergoing Carotid Artery Stenting Via the Transcarotid Artery Revascularization Approach

for
Carotid Artery Diseases
Location: New York NY, Rochester NY, Cincinnati OH,
Sponsor: InspireMD

Sex: All

Age: 18 - 70+

Code: NCT06653387

Recruiting

PUL-042 Treatment in Patients With Parainfluenza Virus (PIV), Human Metapneumovirus (hMPV) or Respiratory Syncytial Virus (RSV)

for
Hematologic Malignancies,
Location: Boston MA, Hackensack NJ, Baltimore MD, Chapel Hill NC,
Sponsor: Pulmotect, Inc.

Sex: All

Age: 18+

Code: NCT06665100

Phase 2, Recruiting

Examining Blood and Tissue Samples to Identify Diagnostic Markers in Patients With Metastatic Cancer Undergoing Tumor Removal

for
Hematopoietic and Lymphoid System Neoplasm,
Location: Rochester MN
Sponsor: Mayo Clinic

Sex: All

Age: 18+

Code: NCT05530759

Recruiting

Upper Body Subcutaneous Exosome Release in Response to a Meal in Obesity

for
Obesity
Location: Rochester MN
Sponsor: Mayo Clinic

Sex: All

Age: 18 - 55

Code: NCT07031297

Recruiting

Optimization of a Behavioral Intervention to Increase Physical Activity in Older Adults Living With HIV

for
Hiv, Physical Inactivity, Aging
Location: Providence RI, Minneapolis MN
Sponsor: Butler Hospital

Sex: All

Age: 50+

Code: NCT05752500

Recruiting

VE303 for Prevention of Recurrent Clostridioides Difficile Infection

for
Clostridium Difficile, Clostridium Difficile Infections,
Location: St. John's, Moncton, Boston MA, Bristol CT, Hamden CT,
Sponsor: Vedanta Biosciences, Inc.

Sex: All

Age: 12+

Code: NCT06237452

Phase 3, Recruiting

Study of the Shockwave Medical SkyRunner Carotid Intravascular Lithotripsy (IVL) System for the Treatment of Calcified Carotid Arteries Prior to Trans-Carotid Stenting (SKYWARD Trans-Carotid IDE [Investigational Device Exemption] Study)

for
Carotid Artery Calcification, Carotid Artery Diseases
Location: Boston MA, New York NY, Wynnewood PA,
Sponsor: Shockwave Medical, Inc.

Sex: All

Age: 18+

Code: NCT07062471

Recruiting

Study of ORIC-114 in Patients With Advanced Solid Tumors Harboring an EGFR or HER2 Alteration

for
Solid Tumors
Location: Boston MA, New Haven CT, New York NY, Philadelphia PA,
Sponsor: ORIC Pharmaceuticals

Sex: All

Age: 18+

Code: NCT05315700

Phase 1, Phase 2, Recruiting

USCRI READY4Life Program

for
Communication, Problem Solving, Social Relationships,
Location: Colchester VT, Philadelphia PA, Raleigh NC, Miami FL,
Sponsor: US Committee for Refugees and Immigrants

Sex: All

Age: 14 - 24

Code: NCT05476185

Recruiting

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

for
B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma,
Location: St. John's, Halifax, Bangor ME, Scarborough ME,
Sponsor: Children's Oncology Group

Sex: All

Age: 1 - 25

Code: NCT03959085

Phase 3, Recruiting

Dose-escalation and Dose-expansion Study of Safety of Azer-cel (PBCAR0191) in Participants With Relapsed/Refractory (r/r) Non-Hodgkin Lymphoma (NHL) and r/r B-cell Acute Lymphoblastic Leukemia (B-ALL)

for
Non-Hodgkin Lymphoma, B-cell Acute Lymphoblastic Leukemia,
Location: Boston MA, Providence RI, New York NY, Baltimore MD,
Sponsor: Imugene Limited

Sex: All

Age: 18+

Code: NCT03666000

Phase 1, Recruiting

Chemotherapy for the Treatment of Patients With Newly Diagnosed Very Low-Risk and Low Risk Fusion Negative Rhabdomyosarcoma

for
Embryonal Rhabdomyosarcoma,
Location: Halifax, Scarborough ME, Boston MA, Providence RI,
Sponsor: Children's Oncology Group

Sex: All

Age: 0 - 21

Code: NCT05304585

Phase 3, Recruiting

ATTUNE: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Intrathecally-Administered ION440 in Participants With Methyl CpG Binding Protein 2 (MECP2) Duplication Syndrome (MDS)

for
Methyl CpG Binding Protein 2 (MECP2) Duplication Syndrome
Location: Boston MA, Philadelphia PA, Baltimore MD, Nashville TN,
Sponsor: Ionis Pharmaceuticals, Inc.

Sex: Male

Age: 2 - 65

Code: NCT06430385

Phase 1, Phase 2, Recruiting

Popular cities in Minnesota

Minnesota offers a strong healthcare network and renowned medical research institutions, making it a prominent hub for a wide range of clinical trials. Leading organizations such as the Mayo Clinic, University of Minnesota Medical School, and Hennepin Healthcare are at the forefront of cutting-edge research.

These institutions are recognized globally for their contributions to medical advancements, placing Minnesota as a key player in clinical trials across various medical fields, from cancer and cardiovascular research to neurological and rare diseases.

Why choose Minnesota for clinical trials?

For people considering participation in a clinical trial, Minnesota provides distinct advantages. The state is home to a diverse and engaged population, which enriches the pool of participants and enhances the relevance of research findings. Minnesota is also renowned for its innovative healthcare landscape, highlighted by institutions that are at the forefront of medical research and technological advancements.

By choosing to participate in a clinical trial in Minnesota, participants can contribute to significant medical research while benefiting from a well-established and collaborative clinical research environment that prioritizes patient safety and care.

Common conditions studied in Minnesota

Local regulations and guidelines

Benefits of participating in clinical trials

How to enroll in a clinical trial in Minnesota